In 2022, the global Intraoperative Radiation Therapy Systems Market is expected to be worth US$ 55.9 million. The application of therapeutic stages of radiation to the tumour site is known as IORT. IORT is frequently used in the multidisciplinary treatment of privately advanced and recurring disease, alongside outer beam radiation, chemotherapy, and surgery.
As a recent trend, IORT can also be used to treat earlier stage disorders, for example, breast cancer growth and prostate cancer. The entire demand for intraoperative radiation treatment equipment is expected to increase at a 7.7% CAGR between 2022 and 2032, reaching approximately US$ 126.8 million by 2032.
Intraoperative radiation therapy systems (IORT) used to destroy the microscopic tumor cells after surgery, intraoperative radiation therapy delivers a concentrated dose of radiation to a tumor site immediately after a tumor is removed. Because of differential radiation or intrabeam properties, the spectrum is used to identify the microbial composition inside the cells. IORT is the application of therapeutic stages of radiation to the tumor site.
Key Players
The writer will create content on the general strategies of market players. And then will write the key players in the market are: IntraOp Medical, Inc., Ariane Medical Systems Ltd, Varian Medical Systems, Inc., Carl Zeiss AG, Eckert & Ziegler, Sensus Healthcare, iCAD Inc., Elekta AB, SIT - S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co.,Ltd., GMV, Brainlab AG, and others.
Segmentation
The report provides insights on the important highlights and current trends prevailing in the market. This helps the readers to gain a deeper understanding and form an unbiased opinion on the market. Numerous segmentations have been provided for this market based on:
Get More Details@ https://www.futuremarketinsights.com/reports/intraoperative-radiation-therapy-systems-market
Segmentation based on Disease Indication:
- Brain Tumors
- Breast Cancer
- Gastrointestinal Tumors
- Head & Neck Tumors
- Skin Cancer
- Spinal Metastases
- Others
Segmentation based on End User
- Hospitals
- Specialty Clinics
- Ambulatory & Surgical Centers
- Others